These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21160609)

  • 1. Contribution of oxidative stress to pulmonary arterial hypertension.
    Demarco VG; Whaley-Connell AT; Sowers JR; Habibi J; Dellsperger KC
    World J Cardiol; 2010 Oct; 2(10):316-24. PubMed ID: 21160609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.
    DeMarco VG; Habibi J; Whaley-Connell AT; Schneider RI; Heller RL; Bosanquet JP; Hayden MR; Delcour K; Cooper SA; Andresen BT; Sowers JR; Dellsperger KC
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2659-68. PubMed ID: 18424632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen and nitrogen species in pulmonary hypertension.
    Tabima DM; Frizzell S; Gladwin MT
    Free Radic Biol Med; 2012 May; 52(9):1970-86. PubMed ID: 22401856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.
    DeMarco VG; Habibi J; Whaley-Connell AT; Schneider RI; Sowers JR; Andresen BT; Gutweiler AA; Ma L; Johnson MS; Ferrario CM; Dellsperger KC
    Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1128-39. PubMed ID: 19633211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species as therapeutic targets in pulmonary hypertension.
    Freund-Michel V; Guibert C; Dubois M; Courtois A; Marthan R; Savineau JP; Muller B
    Ther Adv Respir Dis; 2013 Jun; 7(3):175-200. PubMed ID: 23328248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension.
    Fulton DJR; Li X; Bordan Z; Haigh S; Bentley A; Chen F; Barman SA
    Antioxidants (Basel); 2017 Jul; 6(3):. PubMed ID: 28684719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blueberry extract decreases oxidative stress and improves functional parameters in lungs from rats with pulmonary arterial hypertension.
    Türck P; Fraga S; Salvador I; Campos-Carraro C; Lacerda D; Bahr A; Ortiz V; Hickmann A; Koetz M; Belló-Klein A; Henriques A; Agostini F; da Rosa Araujo AS
    Nutrition; 2020 Feb; 70():110579. PubMed ID: 31743815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
    Kurosawa R; Satoh K; Nakata T; Shindo T; Kikuchi N; Satoh T; Siddique MAH; Omura J; Sunamura S; Nogi M; Takeuchi Y; Miyata S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1205-1217. PubMed ID: 33472404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel P2X7 receptor antagonist PKT100 improves cardiac function and survival in pulmonary hypertension by direct targeting of the right ventricle.
    Hansen T; Karimi Galougahi K; Besnier M; Genetzakis E; Tsang M; Finemore M; O'Brien-Brown J; Di Bartolo BA; Kassiou M; Bubb KJ; Figtree GA
    Am J Physiol Heart Circ Physiol; 2020 Jul; 319(1):H183-H191. PubMed ID: 32469637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
    Budas GR; Boehm M; Kojonazarov B; Viswanathan G; Tian X; Veeroju S; Novoyatleva T; Grimminger F; Hinojosa-Kirschenbaum F; Ghofrani HA; Weissmann N; Seeger W; Liles JT; Schermuly RT
    Am J Respir Crit Care Med; 2018 Feb; 197(3):373-385. PubMed ID: 28910144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension.
    Huetsch JC; Suresh K; Shimoda LA
    Antioxidants (Basel); 2019 Mar; 8(3):. PubMed ID: 30841544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension.
    Mikhael M; Makar C; Wissa A; Le T; Eghbali M; Umar S
    Front Physiol; 2019; 10():1233. PubMed ID: 31607955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
    Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
    Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
    Ogura S; Shimosawa T; Mu S; Sonobe T; Kawakami-Mori F; Wang H; Uetake Y; Yoshida K; Yatomi Y; Shirai M; Fujita T
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H155-62. PubMed ID: 23686713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.